After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Recently, Yahoo Finance discussed the stock, revealing that Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
AVIR belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Atea Pharmaceuticals Inc is $359.63M. A total of 0.6 million shares were traded on the day, compared to an average of 486.94K shares.
Insider Activity
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, AVIR has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, Sommadossi Jean-Pierre sold 56,910 shares of AVIR for 3.85 per share on Feb 01. After the transaction, the President, CEO, and Chairman now owns 116,557 company shares. In a previous transaction on Feb 01, Horga Maria Arantxa sold 15,870 shares at 3.84 per share. AVIR shares that Chief Medical Officer owns now total 25,664.
Among the insiders who sold shares, Corcoran Andrea disposed of 15,843 shares on Feb 01 at a per-share price of $3.84. This resulted in the insider holding 670,208 shares of AVIR after the transaction. In another insider transaction, Hammond Janet MJ sold 14,029 shares at $3.84 per share on Feb 01. Company shares held by the Chief Development Officer now total 35,362.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for AVIR in the last 3 months, the mean price target is $3.50 with high estimates of $5.00 and low estimates of $2.00. In terms of 52-week highs and lows, AVIR has a high of $5.19 and a low of $2.77.
As of this writing, AVIR has an earnings estimate of -$0.5 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of -$0.48 per share and a lower estimate of -$0.52. The company reported an EPS of -$0.34 in the last quarter, which was 27.70% higher than expectations of -$0.47.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. AVIR’s latest balance sheet shows that the firm has $764.38M in Cash & Short Term Investments as of fiscal 2021. There were $197.00k in debt and $56.88M in liabilities at the time. Its Book Value Per Share was $6.97, while its Total Shareholder’s Equity was $710.08M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AVIR is Buy with a score of 2.75.
